Highland Capital Management (Texas)’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q2 | $29.9M | Buy |
1,606,942
+561,550
| +54% | +$10.4M | 1.75% | 11 |
|
2019
Q1 | $25.6M | Sell |
1,045,392
-14,400
| -1% | -$352K | 1.59% | 10 |
|
2018
Q4 | $27.5M | Buy |
1,059,792
+214,750
| +25% | +$5.57M | 2.11% | 10 |
|
2018
Q3 | $26.7M | Sell |
845,042
-58,815
| -7% | -$1.86M | 1.48% | 10 |
|
2018
Q2 | $35.1M | Sell |
903,857
-587,712
| -39% | -$22.8M | 1.99% | 8 |
|
2018
Q1 | $41.2M | Sell |
1,491,569
-2,606
| -0.2% | -$71.9K | 2.12% | 6 |
|
2017
Q4 | $27M | Sell |
1,494,175
-7,002
| -0.5% | -$127K | 1.24% | 14 |
|
2017
Q3 | $24.2M | Sell |
1,501,177
-110,925
| -7% | -$1.79M | 1.07% | 10 |
|
2017
Q2 | $22.3M | Sell |
1,612,102
-32,050
| -2% | -$444K | 0.95% | 20 |
|
2017
Q1 | $24.7M | Buy |
1,644,152
+81,335
| +5% | +$1.22M | 1.25% | 13 |
|
2016
Q4 | $20.5M | Buy |
1,562,817
+912,086
| +140% | +$11.9M | 0.96% | 24 |
|
2016
Q3 | $11.2M | Buy |
+650,731
| New | +$11.2M | 0.34% | 43 |
|